Navigation Links
Heartburn Drugs May Raise Pneumonia Risk
Date:12/20/2010

By Jenifer Goodwin
HealthDay Reporter

MONDAY, Dec. 20 (HealthDay News) -- Popular heartburn drugs, including proton pump inhibitors and histamine-2 receptor antagonists, may raise the risk of pneumonia, new research finds.

Researchers in Korea analyzed the results of 31 studies on heartburn drugs published between 1985 and 2009.

"Our results suggest that the use of acid suppressive drugs is associated with an increased risk of pneumonia," said Dr. Sang Min Park of the department of family medicine at Seoul National University Hospital in Korea.

"Patients should be cautious at overuse of acid-suppressive drugs, both high-dose and long duration," he added.

Sales of these enormously popular drugs -- the second best-selling category of medications worldwide -- reached nearly $27 billion in the United States in 2005, according to background information in the study, published Dec. 20 in CMAJ (Canadian Medical Association Journal).

Proton pump inhibitors (PPIs) reduce acid production in the stomach and are used to treat heartburn, gastroesophageal reflux disease (GERD) and gastric ulcers. They include omeprazole (Prilosec), lansoprazole (Prevacid) and esomeprazole (Nexium).

Histamine-2 receptor antagonists, often called H2 blockers, use a different mechanism to reduce stomach acid and include cimetidine (Tagamet), famotidine (Pepcid), nizatidine (Axid) and ranitidine (Zantac).

According to Consumer Reports, sales of a Nexium alone hit $4.8 billion in 2008.

Yet recently, studies have raised concerns about the drugs. Several studies have linked PPIs to a higher risk of fractures and an infection with a bacterium called Clostridium difficile.

Some previous studies also linked heartburn drugs to a higher risk of pneumonia, but the research has been mixed, according to the study authors.

Their meta-analysis combined the results of eight observational studies t
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. For Most, Chronic Heartburn Not a Big Risk for Esophageal Cancer
2. No Link Between Heartburn Drugs and Birth Defects: Study
3. Heartburn Drugs, Plavix Seem Safe to Take Together
4. Plavix, Heartburn Drug Safe to Take Together: Study
5. FDA Warns of Fracture Risk With Popular Heartburn Drugs
6. Coming Soon: A Low-Heartburn Coffee?
7. Trio of drugs may combat triple negative breast cancer
8. Drugs are safe, active in patients normally ineligible for clinical trial
9. Certain Breast Cancer Drugs Linked With Heart Risks in Older Women
10. Economist honored for study on impact of new cancer drugs on life expectancy
11. FDA Panel Votes Against Drugs Said to Prevent Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Heartburn Drugs May Raise Pneumonia Risk
(Date:7/22/2014)... (PRWEB) July 22, 2014 According to ... Health care, Automobile, Aerospace & Defense, Marine and Mining) ... Middle East, and Rest of the world) - Forecast ... is expected to grow at a CAGR 8.00% to ... Europe is estimated to grow at a CAGR of ...
(Date:7/22/2014)... Dimension One Spas’ retailers across the ... all models during the “Let’s Take This Outside” Summer ... http://www.d1spas.com/financing for more information and to apply. ... offers a wide variety of outdoor hot tubs with ... music, customizable massage, and personal controls. , ...
(Date:7/22/2014)... July 22, 2014 (HealthDay News) -- People who suffer ... for a rise in blood pressure, a new study ... health problems and even early death, but few studies ... may be one of the causes, according to the ... people who had been separated or divorced for about ...
(Date:7/22/2014)... has received a five-year, $3 million grant to ... neglect and maltreatment during childhood leave molecular marks ... life. , The Center for Biomarker Research and ... in collaboration with Duke University School of Medicine, ... by the National Institutes of Health, National Institute ...
(Date:7/22/2014)... July 22, 2014 BlogHer, Inc. ... women, this year celebrates its tenth anniversary where it ... of attendees, including community leaders from the new women’s ... every consumer vertical, will converge in San Jose this ... and a “selfiebration” of social technology. , BlogHer’s ...
Breaking Medicine News(10 mins):Health News:Global Actuators Market Estimated to Reach $59.32 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Global Actuators Market Estimated to Reach $59.32 Billion by 2019 – New Report by MarketsandMarkets 3Health News:Global Actuators Market Estimated to Reach $59.32 Billion by 2019 – New Report by MarketsandMarkets 4Health News:Sleepless Nights After Divorce May Be Tied to Blood Pressure Rise 2Health News:VCU receives grant to study molecular marks left by childhood adverse experiences 2Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 2Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 3Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 4
... Calif., Aug. 6 IRIDEX Corporation (NASDAQ: IRIX ) today ... the market closes on Thursday, August 13, 2009. ... call with the investment community at 5:00 p.m. Eastern Time ... discuss the results of the quarter and other business developments. , ...
... ,Is the White House looking to intimidate and silence opponents?, asks FRC,s ... In a web video released today, Family Research Council ( FRC ... send the White House any email or health care messages deemed "fishy." ... ) , , Family Research Council President ...
... OAK BROOK, Ill., Aug. 6 SedationFacts.org, ... gastroenterology fellows, announces enhancements to the sedation administration standards ... administration information and reliable links to other state resources. ... regulations governing sedation administration by nursing personnel vary from ...
... on the way for anyone who has ever gotten lost ... is in the form of health-care signage symbols being developed ... other U.S. universities. These symbols will be tested this ... of surveys taken among the populations in three Midwestern cities, ...
... viral, bacterial infections, study finds , THURSDAY, Aug. ... appears able to identify people who,ve been exposed to ... flu, even before symptoms develop. , In a study ... a live cold virus, respiratory syncytial virus or influenza ...
... EXTON, Pa., Aug. 6 ViroPharma Incorporated (Nasdaq: VPHM ... clinical trial for NTCD (non-toxigenic Clostridium difficile ), a novel ... NTCD contains the spores of a non-toxin producing strain of ... "Colonization of the large bowel with non-toxin producing strains of ...
Cached Medicine News:Health News:White House Launches 'Fishy' Expedition 2Health News:Sedationfacts.org Enhances State-Specific Site Content, Making Regional Sedation Administration Standards and Regulations Quick and Easy to Find and Use 2Health News:Sedationfacts.org Enhances State-Specific Site Content, Making Regional Sedation Administration Standards and Regulations Quick and Easy to Find and Use 3Health News:Sedationfacts.org Enhances State-Specific Site Content, Making Regional Sedation Administration Standards and Regulations Quick and Easy to Find and Use 4Health News:UC design research points the way so you won't get lost at the hospital 2Health News:UC design research points the way so you won't get lost at the hospital 3Health News:UC design research points the way so you won't get lost at the hospital 4Health News:Cold, Flu or Pneumonia? Answer May Lie in Blood Test 2Health News:ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program 2Health News:ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program 3Health News:ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program 4
(Date:7/22/2014)... York , July 22, 2014 ... Transparency Market Research "Process Spectroscopy Market (Technology Types - Near ... spectroscopy) Market - Global Industry Analysis, Size, Share, Growth, Trends ... USD 714.5 million in 2012 and is expected to grow ... North America was the largest ...
(Date:7/22/2014)... July 22, 2014 BiologicTx ® today ... first 3-way Kidney Paired Donation transplant exchange utilizing BiologicTx,s ... on July 9 at the Miami Transplant Institute, located ... Kidney Paired Donation (KPD) ... compatible for kidney transplant with one another due to ...
(Date:7/22/2014)... , July 22, 2014 Sanofi Pasteur, the ... SNY ), announced today that the first lots of Fluzone ... season have been released by the U.S. Food and Drug ... 21, 2014, representing the first of at least 65 million ... will be delivered to U.S. health care providers and pharmacies ...
Breaking Medicine Technology:Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 2Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 3Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 4BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 2Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 3Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 4Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 5Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 6Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 7
... Bacterin International Holdings, Inc. ("Bacterin") (NYSE Amex: ... revolutionary bone graft material and antimicrobial coatings for medical ... the Company,s third human acellular biological scaffold, hMatrix®, an ... an acellular matrix processed from donated human dermal tissue ...
... 5, 2011 AmbiCom Holdings, Inc. (OTCQB:ABHI), ... medical equipment suppliers, today announced that it has retained ... firm, to develop and implement a strategic investor relations ... with the investment community. "Wireless medical ...
Cached Medicine Technology:Bacterin International Holdings Launches Third Biologic Scaffold 2Bacterin International Holdings Launches Third Biologic Scaffold 3AmbiCom Retains Hayden IR to Develop Strategic Investor Relations Program 2AmbiCom Retains Hayden IR to Develop Strategic Investor Relations Program 3
Non-Illuminated Trial Lens Set with lenses mounted in plastic frames....
Illuminated Trial Lens Set is an attractive set of trial lenses worked to a high standard of accuracy....
Minus cylinders only trial lens set....
Full Trial Lens Set....
Medicine Products: